Skip to content

Treatment of Morbihan disease

Document Type
Publications · Journal Article
Registered DB
KCIScopus
Journal Ranking
Scopus Q4KCI Q2
Journal
Archives of Craniofacial Surgery22(3) · pp.131 · 2021
Citation
Scopus 14KCI 1
FWCI (Scopus)
1.82
ISSN
2287-1152

Authors

  1. Kim, Joo-hyungFirst authorCorresponding authorDepartment of Plastic and Reconstructive Surgery, Pusan National University School of Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, Korea

Abstract

Morbihan disease (MD) is a rare condition that involves rosaceous lymphedema or erythematous lymphedema of the middle and upper thirds of the face. It typically affects the periorbital region, forehead, glabella, nose, and cheeks. The etiology of MD remains unclear, and its diagnosis is challenging. MD often tends to be unresponsive to therapies commonly used to treat rosacea, including corticosteroids, isotretinoin, and antibiotics. Surgical treatments have therefore been attempted, but most cases showed unsatisfactory responses. These problems could have resulted from an incorrect recognition and interpretation of the pathophysiology of MD and inaccurate planning of the operation, resulting in recurrence or exacerbation of edema.

Keywords

Edema / Eyelids / Lymphedema

Identifiers

Scopus EID
2-s2.0-85110446590
KCI
ART002725503